Intellectual Property

Vaccination

blog
Vaccine Hesitancy, Working from Home, Arctic Diplomacy: RAND Weekly Recap
This weekly recap focuses on vaccine hesitancy as a symptom of ‘Truth Decay,’ how to make remote work beneficial for all, U.S. Arctic diplomacy, and more.
Read More »
May 21, 2021

Vaccination

commentary
Vaccine Patents Debate Risks Becoming a Sideshow in the Global Battle Against COVID-19
As COVID-19 cases continue to surge around the world, the debate is raging over whether patents on existing vaccines should be waived. But the global community could view patent waivers as just one of many available tools for speeding up vaccine delivery worldwide.
Read More »
May 17, 2021
The Hill
Krishna B. Kumar
Science and Technology Legislation

commentary
Scientific Research Integrity Demands Transparency—the Law Should Require It Too
China pays U.S. scientists for their innovations in exchange for money and access to research laboratories and speaking and publication opportunities. They require the researchers to keep these agreements secret from their employers or the U.S. government. Perhaps it is time to codify scientific transparency into law.
Read More »
Apr 12, 2021
Cortney Weinbaum @cortney_dc
Vaccination

commentary
Needed: A Blueprint for a Post-Vaccine World
When a COVID-19 vaccine is developed, many in rich countries may be able to afford it while the poor and uninsured may not. The time to plan for equitable access, financing, intellectual property rights, and global production is now.
Read More »
May 11, 2020
The Hill
Krishna B. Kumar, Mahshid Abir, et al.
Data Privacy

commentary
ACTA Revisited? TTIP and Data Privacy
The EU has embarked on negotiations with the U.S. on the TTIP, which shares some of ACTA's goals. This time, though, the European Commission is seeking to make the talks more transparent by publishing a series of position papers on key issues very early on in the process. This is a step in the right direction toward an agreement that will have economic benefits for a net-exporting region of intellectual property such as the EU.
Read More »
Nov 26, 2014
Atlantic Community
Marlon Graf
Science, Technology, and Innovation Policy

commentary
A New Model for Open Innovation: The Structural Genomics Consortium
Open innovation is often suggested as a solution to enhance productivity in under-performing areas of research. Now, the strengths and weaknesses of a new open innovation model in drug discovery have been evaluated.
Read More »
Mar 25, 2014
EuroScientist
Sophie Castle-Clarke
Intellectual Property

commentary
The Costs of Counterfeiting
A new RAND report points to a potential solution to understanding the real economic losses associated with intellectual property infringement.
Read More »
Nov 28, 2012
The RAND Blog
Stijn Hoorens @StijnHoorens

Quoted

The COP decisionmaking process reflects its members' consensus views. And therein lies the problem. The Paris Agreement should have achieved the socially better outcomes of binding emissions control to finance and binding each country to its target of emissions and finance.…That it did not do so was because the coalitions' views prevailed rather than the social good.

Rafiq Dossani

Director, RAND Center for Asia Pacific Policy

Source: United Press International

Women have fought in wars for as long as humans have waged them. Yet that long history has been either lost or purposefully hidden, complicating efforts to expand women's military roles even as we have steadily gained greater equality in other fields.

Kayla M. Williams

Senior Policy Researcher

Source: Association of the U.S. Army

Using AI to Identify Youth Suicide Risk: What Does the Evidence Say?

Disrupting the Chinese Military in Competition and Low-Intensity Conflict

America's Indo-Pacific Alliances Are Astonishingly Strong

Resilient Reconstruction in Ukraine

Preventing Domestic Violent Extremism: Insights from RAND Research

The Policy Currents Podcast

Developing Strategies for Summer Learning

Improving Psychological Wellbeing and Work Outcomes in the UK

Planning for the Rising Costs of Dementia

Helping Coastal Communities Plan for Climate Change

Intellectual Property

Vaccine Hesitancy, Working from Home, Arctic Diplomacy: RAND Weekly Recap

Vaccine Patents Debate Risks Becoming a Sideshow in the Global Battle Against COVID-19

Scientific Research Integrity Demands Transparency—the Law Should Require It Too

Needed: A Blueprint for a Post-Vaccine World

ACTA Revisited? TTIP and Data Privacy

A New Model for Open Innovation: The Structural Genomics Consortium

The Costs of Counterfeiting

Connect

Contact Us

I am interested in

Follow

Stay Informed

Resources

Site Information